vs
Side-by-side financial comparison of Douglas Emmett Inc (DEI) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Douglas Emmett Inc is the larger business by last-quarter revenue ($249.4M vs $168.4M, roughly 1.5× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 1.8%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 0.9%).
Douglas Emmett Inc is a leading real estate investment trust (REIT) that owns, operates, and acquires high-quality office and multifamily residential properties. Its core operation areas are high-barrier-to-entry markets including Los Angeles in California and Honolulu in Hawaii, serving premium commercial and residential tenant segments.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
DEI vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $249.4M | $168.4M |
| Net Profit | $-6.8M | — |
| Gross Margin | 62.2% | — |
| Operating Margin | — | 50.6% |
| Net Margin | -2.7% | — |
| Revenue YoY | 1.8% | 143.7% |
| Net Profit YoY | -670.7% | — |
| EPS (diluted) | $-0.04 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $249.4M | $168.4M | ||
| Q3 25 | $250.6M | $87.3M | ||
| Q2 25 | $252.4M | $82.4M | ||
| Q1 25 | $251.5M | $65.0M | ||
| Q4 24 | $245.0M | $69.1M | ||
| Q3 24 | $250.8M | $51.6M | ||
| Q2 24 | $245.8M | $73.8M | ||
| Q1 24 | $245.0M | $137.7M |
| Q4 25 | $-6.8M | — | ||
| Q3 25 | $-10.9M | $-31.3M | ||
| Q2 25 | $-5.8M | $-12.7M | ||
| Q1 25 | $39.8M | $-40.5M | ||
| Q4 24 | $-888.0K | — | ||
| Q3 24 | $4.6M | $-29.5M | ||
| Q2 24 | $10.9M | $-61.9M | ||
| Q1 24 | $8.9M | $61.0M |
| Q4 25 | 62.2% | — | ||
| Q3 25 | 63.6% | — | ||
| Q2 25 | 63.2% | — | ||
| Q1 25 | 64.4% | — | ||
| Q4 24 | 63.5% | — | ||
| Q3 24 | 62.2% | — | ||
| Q2 24 | 66.2% | — | ||
| Q1 24 | 66.1% | — |
| Q4 25 | — | 50.6% | ||
| Q3 25 | — | -11.4% | ||
| Q2 25 | — | 8.6% | ||
| Q1 25 | — | -34.0% | ||
| Q4 24 | — | -6.4% | ||
| Q3 24 | — | -31.0% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 52.5% |
| Q4 25 | -2.7% | — | ||
| Q3 25 | -4.3% | -35.9% | ||
| Q2 25 | -2.3% | -15.4% | ||
| Q1 25 | 15.8% | -62.2% | ||
| Q4 24 | -0.4% | — | ||
| Q3 24 | 1.8% | -57.2% | ||
| Q2 24 | 4.4% | -83.9% | ||
| Q1 24 | 3.6% | 44.3% |
| Q4 25 | $-0.04 | $0.32 | ||
| Q3 25 | $-0.07 | $-0.16 | ||
| Q2 25 | $-0.04 | $-0.06 | ||
| Q1 25 | $0.24 | $-0.21 | ||
| Q4 24 | $-0.01 | $-0.14 | ||
| Q3 24 | $0.03 | $-0.15 | ||
| Q2 24 | $0.06 | $-0.33 | ||
| Q1 24 | $0.05 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $340.8M | $167.9M |
| Total DebtLower is stronger | $5.5B | — |
| Stockholders' EquityBook value | $1.9B | $-302.0M |
| Total Assets | $9.3B | $465.9M |
| Debt / EquityLower = less leverage | 2.91× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $340.8M | $167.9M | ||
| Q3 25 | $408.5M | $92.4M | ||
| Q2 25 | $426.9M | $86.1M | ||
| Q1 25 | $525.7M | $114.6M | ||
| Q4 24 | $444.6M | $144.8M | ||
| Q3 24 | $544.2M | $144.7M | ||
| Q2 24 | $561.1M | $189.3M | ||
| Q1 24 | $556.7M | $226.6M |
| Q4 25 | $5.5B | — | ||
| Q3 25 | $5.6B | — | ||
| Q2 25 | $5.6B | — | ||
| Q1 25 | $5.6B | — | ||
| Q4 24 | $5.5B | — | ||
| Q3 24 | $5.5B | — | ||
| Q2 24 | $5.5B | — | ||
| Q1 24 | $5.5B | — |
| Q4 25 | $1.9B | $-302.0M | ||
| Q3 25 | $1.9B | $-451.4M | ||
| Q2 25 | $2.0B | $-433.5M | ||
| Q1 25 | $2.0B | $-426.2M | ||
| Q4 24 | $2.1B | $-388.7M | ||
| Q3 24 | $2.1B | $-370.2M | ||
| Q2 24 | $2.2B | $-344.2M | ||
| Q1 24 | $2.2B | $-294.3M |
| Q4 25 | $9.3B | $465.9M | ||
| Q3 25 | $9.4B | $364.0M | ||
| Q2 25 | $9.4B | $347.1M | ||
| Q1 25 | $9.6B | $324.0M | ||
| Q4 24 | $9.4B | $343.8M | ||
| Q3 24 | $9.5B | $314.1M | ||
| Q2 24 | $9.6B | $352.3M | ||
| Q1 24 | $9.6B | $373.1M |
| Q4 25 | 2.91× | — | ||
| Q3 25 | 2.85× | — | ||
| Q2 25 | 2.78× | — | ||
| Q1 25 | 2.75× | — | ||
| Q4 24 | 2.67× | — | ||
| Q3 24 | 2.64× | — | ||
| Q2 24 | 2.56× | — | ||
| Q1 24 | 2.52× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $386.9M | $45.2M |
| Free Cash FlowOCF − Capex | $194.5M | — |
| FCF MarginFCF / Revenue | 78.0% | — |
| Capex IntensityCapex / Revenue | 77.1% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $376.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.9M | $45.2M | ||
| Q3 25 | $109.8M | $-4.3M | ||
| Q2 25 | $81.3M | $-31.4M | ||
| Q1 25 | $132.6M | $-22.6M | ||
| Q4 24 | $408.7M | $-35.0M | ||
| Q3 24 | $103.7M | $-35.3M | ||
| Q2 24 | $91.9M | $-7.2M | ||
| Q1 24 | $139.0M | $53.8M |
| Q4 25 | $194.5M | — | ||
| Q3 25 | $61.9M | — | ||
| Q2 25 | $30.2M | — | ||
| Q1 25 | $90.3M | — | ||
| Q4 24 | $241.4M | — | ||
| Q3 24 | $63.2M | $-35.5M | ||
| Q2 24 | $52.2M | $-7.3M | ||
| Q1 24 | $90.9M | $53.8M |
| Q4 25 | 78.0% | — | ||
| Q3 25 | 24.7% | — | ||
| Q2 25 | 11.9% | — | ||
| Q1 25 | 35.9% | — | ||
| Q4 24 | 98.5% | — | ||
| Q3 24 | 25.2% | -68.7% | ||
| Q2 24 | 21.2% | -9.9% | ||
| Q1 24 | 37.1% | 39.0% |
| Q4 25 | 77.1% | 0.0% | ||
| Q3 25 | 19.1% | 0.0% | ||
| Q2 25 | 20.3% | 0.0% | ||
| Q1 25 | 16.8% | 0.0% | ||
| Q4 24 | 68.3% | 0.0% | ||
| Q3 24 | 16.1% | 0.3% | ||
| Q2 24 | 16.1% | 0.1% | ||
| Q1 24 | 19.6% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.33× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 22.46× | — | ||
| Q2 24 | 8.44× | — | ||
| Q1 24 | 15.60× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DEI
| Rental Revenue And Tenant Recovery Revenue | $169.4M | 68% |
| Multifamily Segment | $49.9M | 20% |
| Parking Revenue And Other Income | $30.2M | 12% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
